Cell line authentication to improve preclinical cancer research: Policies and training

L. Freedman, V. Siegel
{"title":"Cell line authentication to improve preclinical cancer research: Policies and training","authors":"L. Freedman, V. Siegel","doi":"10.1158/AACR.EDB-15-9039","DOIUrl":null,"url":null,"abstract":"Irreproducible research is a pervasive, expensive, and well-recognized problem that con-tributes to both delays and costs of drug discovery and development (1, 2). One common and preventable contributor to irreproducible cancer research is the widespread use of misidenti fi ed (e.g., cellular cross-contamination), mislabeled, or interspecies-contaminated cell lines (3). Immortalized cancer cell lines have been used for decades as preclinical models for drug target discovery and in multiple areas of biomedical research (4). At the same time, the problem of altered genotypic and phenotypic function (i.e., \"drift\") as a result of over-passaging of cell lines also persists (5). The Global Biological Standards Institute (GBSI), a Washington, D.C.-based nonpro fi t, is leading a multipartner effort to build awareness among cancer researchers regarding the importance of cell authentication and to actively change laboratory practices and policies to produce more credible, reproducible, and translatable preclinical data and studies. As a result of targeted training, effective policies, and use of standards and best practices for authentication and cell culturing, (1) knowledge of why and how to perform cell authentication will improve, (2) research reproducibility problems involving cell lines will decrease, (3) millions of dollars in wasted research expenditures will be saved, and (4) translation time from bench to clinic to bedside will be decreased. A companion paper, Cell line authentication to improve preclinical cancer research: Methods in cell line authentication, quality control, and annotation, is also available.","PeriodicalId":404310,"journal":{"name":"Aacr Education Book","volume":"158 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aacr Education Book","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/AACR.EDB-15-9039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Irreproducible research is a pervasive, expensive, and well-recognized problem that con-tributes to both delays and costs of drug discovery and development (1, 2). One common and preventable contributor to irreproducible cancer research is the widespread use of misidenti fi ed (e.g., cellular cross-contamination), mislabeled, or interspecies-contaminated cell lines (3). Immortalized cancer cell lines have been used for decades as preclinical models for drug target discovery and in multiple areas of biomedical research (4). At the same time, the problem of altered genotypic and phenotypic function (i.e., "drift") as a result of over-passaging of cell lines also persists (5). The Global Biological Standards Institute (GBSI), a Washington, D.C.-based nonpro fi t, is leading a multipartner effort to build awareness among cancer researchers regarding the importance of cell authentication and to actively change laboratory practices and policies to produce more credible, reproducible, and translatable preclinical data and studies. As a result of targeted training, effective policies, and use of standards and best practices for authentication and cell culturing, (1) knowledge of why and how to perform cell authentication will improve, (2) research reproducibility problems involving cell lines will decrease, (3) millions of dollars in wasted research expenditures will be saved, and (4) translation time from bench to clinic to bedside will be decreased. A companion paper, Cell line authentication to improve preclinical cancer research: Methods in cell line authentication, quality control, and annotation, is also available.
细胞系认证提高临床前癌症研究:政策和培训
不可重复性研究是一个普遍存在的、昂贵的、公认的问题,它导致了药物发现和开发的延迟和成本(1,2)。不可重复性癌症研究的一个常见且可预防的因素是广泛使用错误识别(例如细胞交叉污染)、错误标记、或种间污染细胞系(3)。几十年来,永生化癌细胞系一直被用作药物靶点发现和生物医学研究多个领域的临床前模型(4)。与此同时,由于细胞系的过度传代,基因型和表型功能改变(即“漂移”)的问题也一直存在(5)。全球生物标准研究所(GBSI)是一家总部位于华盛顿特区的非营利组织,正在领导一项多方合作努力,在癌症研究人员中建立对细胞认证重要性的认识,并积极改变实验室实践和政策,以产生更可信、可重复和可翻译的临床前数据和研究。由于有针对性的培训,有效的政策,以及认证和细胞培养标准和最佳实践的使用,(1)对为什么和如何进行细胞认证的了解将会提高,(2)涉及细胞系的研究可重复性问题将会减少,(3)将节省数百万美元的浪费研究支出,(4)从实验室到诊所到床边的转换时间将会减少。另一篇论文《细胞系认证以改善临床前癌症研究:细胞系认证、质量控制和注释的方法》也可用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书